BrightSpring Health Services, Inc. Common Stock

Fundamentals5.0
Price Action3.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Margin Improvement
  • High Leverage
  • Rich Valuation

AI
AI Summary

5.0

BTSG has moved from a “can it grow?” story to a “can it sustain high-growth execution long enough to justify a still-rich multiple?” setup, with strong revenue/EBITDA momentum and debt reduction offset by thin free cash flow, acquisition/integration risk, and a chart that still refuses to confirm the fundamentals.

Execution
Valuation
Growth‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Margin Improvement
  • High Leverage
  • Rich Valuation

BTSG is improving modestly on revenue, margins, and cash flow, but high leverage, thin free cash flow, heavy intangibles, and a stretched valuation keep the risk/reward unattractive.

mixed
risk

Price Behavior

3.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Broken trend
  • Support holding
  • Rebound capped

Over the last month, BTSG remains in a short-term downtrend, with buyers defending $59.5–$60.5 but a recovery not confirmed until it reclaims $63.

downtrend
support
Support Level: $59.5–$60.5
Resistance Level: $62.8–$63.0

Sharp drop on 2026-07-30 to 2026-07-31 broke the $69–$73 zone and turned prior support into resistance

Sentiment & News

6.0

Key News Insights:

  • Revenue growth
  • Premium valuation
  • Execution risk

BrightSpring Health Services is posting strong top-line and EBITDA growth with a raised outlook, but its premium valuation and execution/policy risks continue to limit upside.

Growth
Valuation

The news is constructive for BrightSpring's fundamentals and outlook, but the stock may stay range-bound unless management proves sustained margin expansion and absorbs near-term risks